| Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials MV Irazabal, LJ Rangel, EJ Bergstralh, SL Osborn, AJ Harmon, ... Journal of the American Society of Nephrology 26 (1), 160-172, 2015 | 600 | 2015 |
| Rituximab therapy in idiopathic membranous nephropathy: a 2-year study FC Fervenza, RS Abraham, SB Erickson, MV Irazabal, A Eirin, U Specks, ... Clinical journal of the American Society of Nephrology 5 (12), 2188-2198, 2010 | 336 | 2010 |
| Reactive oxygen species and redox signaling in chronic kidney disease MV Irazabal, VE Torres Cells 9 (6), 1342, 2020 | 206 | 2020 |
| Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease CM Heyer, JL Sundsbak, KZ Abebe, AB Chapman, VE Torres, ... Journal of the American Society of Nephrology 27 (9), 2872-2884, 2016 | 170 | 2016 |
| Somatostatin analog therapy for severe polycystic liver disease: results after 2 years MC Hogan, TV Masyuk, L Page, DR Holmes III, X Li, EJ Bergstralh, ... Nephrology Dialysis Transplantation 27 (9), 3532-3539, 2012 | 170 | 2012 |
| Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease MV Irazabal, J Huston III, V Kubly, S Rossetti, JL Sundsbak, MC Hogan, ... Clinical Journal of the American Society of Nephrology 6 (6), 1274-1285, 2011 | 157 | 2011 |
| Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease MV Irazabal, VE Torres, MC Hogan, J Glockner, BF King, TG Ofstie, ... Kidney international 80 (3), 295-301, 2011 | 144 | 2011 |
| Identification of biomarkers for PKD1 using urinary exosomes MC Hogan, JL Bakeberg, VG Gainullin, MV Irazabal, AJ Harmon, ... Journal of the American Society of Nephrology 26 (7), 1661-1670, 2015 | 131 | 2015 |
| Long-term administration of tolvaptan in autosomal dominant polycystic kidney disease ME Edwards, FT Chebib, MV Irazabal, TG Ofstie, LA Bungum, AJ Metzger, ... Clinical Journal of the American Society of Nephrology 13 (8), 1153-1161, 2018 | 87 | 2018 |
| Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy–related kidney diseases N Leung, M Gertz, RA Kyle, FC Fervenza, MV Irazabal, A Eirin, S Kumar, ... Clinical Journal of the American Society of Nephrology 7 (12), 1964-1968, 2012 | 86 | 2012 |
| Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience D Geetha, A Eirin, K True, MV Irazabal, U Specks, P Seo, P Nachman, ... Transplantation 91 (12), 1370-1375, 2011 | 84 | 2011 |
| Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease FT Chebib, Y Jung, CM Heyer, MV Irazabal, MC Hogan, PC Harris, ... Nephrology Dialysis Transplantation 31 (6), 952-960, 2016 | 77 | 2016 |
| Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney A Eirin, MV Irazabal, MA Gertz, A Dispenzieri, MQ Lacy, S Kumar, S Sethi, ... Nephrology Dialysis Transplantation 27 (3), 1097-1101, 2012 | 76 | 2012 |
| A multicenter randomized controlled trial of rituximab versus cyclosporine in the treatment of idiopathic membranous nephropathy (MENTOR) FC Fervenza, PA Canetta, SJ Barbour, RA Lafayette, BH Rovin, N Aslam, ... Nephron 130 (3), 159-168, 2015 | 71 | 2015 |
| Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis F Silva, U Specks, S Sethi, MV Irazabal, FC Fervenza American journal of kidney diseases 54 (3), 542-545, 2009 | 63 | 2009 |
| Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression TL Kline, P Korfiatis, ME Edwards, JD Warner, MV Irazabal, BF King, ... Nephrology Dialysis Transplantation 31 (2), 241-248, 2016 | 62 | 2016 |
| Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody–associated vasculitis with severe kidney disease MC Moura, MV Irazabal, A Eirin, L Zand, S Sethi, BJ Borah, JL Winters, ... Journal of the American Society of Nephrology 31 (11), 2688-2704, 2020 | 61 | 2020 |
| Effects of hydration in rats and mice with polycystic kidney disease K Hopp, X Wang, H Ye, MV Irazabal, PC Harris, VE Torres American Journal of Physiology-Renal Physiology 308 (3), F261-F266, 2015 | 61 | 2015 |
| Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease IM Sanchis, S Shukoor, MV Irazabal, CD Madsen, FT Chebib, MC Hogan, ... Clinical Journal of the American Society of Nephrology 14 (8), 1151-1160, 2019 | 59 | 2019 |
| Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial MV Irazabal, KZ Abebe, KT Bae, RD Perrone, AB Chapman, RW Schrier, ... Nephrology Dialysis Transplantation 32 (11), 1857-1865, 2017 | 59 | 2017 |
